3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
Conditions
Multiple Myeloma
2
Hematologic Neoplasms
2
Erdheim-Chester Disease
2
Xanthogranuloma, Juvenile
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thrombocytosis
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Laryngeal Neoplasms
1
Hodgkin Disease
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Biopsy
2
ulixertinib
1
tipifarnib
1
tazemetostat
1
selpercatinib
1
palbociclib
1
olaparib
1
larotrectinib
1
ivosidenib
1
erdafitinib
1
ensartinib
1
cobimetinib
1
X-Rays
1
Vemurafenib
1
Phantoms, Imaging
1
Nuclear Medicine Department, Hospital
1
Lenalidomide
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Histiocytic Sarcoma
×
cobimetinib
×
Myeloid
×
Clear all
NCT04079179
2025-09-18
NACHO-COBI
Baylor College of Medicine
Phase 2
Recruiting
90 enrolled